Cargando…
Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial
IMPORTANCE: Venous thromboembolism (VTE) is a leading cause of morbidity and mortality after bariatric surgery. Clinical end point studies on thromboprophylaxis with direct oral anticoagulants in patients undergoing bariatric surgery are lacking. OBJECTIVE: To assess the efficacy and safety of a pro...
Autores principales: | Kröll, Dino, Nett, Philipp C., Rommers, Nikki, Borbély, Yves, Deichsel, Fabian, Nocito, Antonio, Zehetner, Jörg, Kessler, Ulf, Fringeli, Yannick, Alberio, Lorenzo, Candinas, Daniel, Stirnimann, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214035/ https://www.ncbi.nlm.nih.gov/pubmed/37227726 http://dx.doi.org/10.1001/jamanetworkopen.2023.15241 |
Ejemplares similares
-
Gastroesophageal Junction and Pylorus Distensibility Before and After Sleeve Gastrectomy—pilot Study with EndoFlip(TM)
por: Magyar, Christian Tibor Josef, et al.
Publicado: (2023) -
Diarrhea after bariatric procedures: Diagnosis and therapy
por: Borbély, Yves M, et al.
Publicado: (2017) -
Thromboprophylaxis after bariatric surgery
por: Almarshad, Feras M., et al.
Publicado: (2020) -
Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature
por: Plitzko, Gabriel, et al.
Publicado: (2020) -
Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
por: Raskob, Gary E., et al.
Publicado: (2022)